Swedish Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Vitrolife

Market Cap: SEK 18.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Swedish Orphan Biovitrum

Market Cap: SEK 93.6b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Saniona

Market Cap: SEK 1.3b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Newbury Pharmaceuticals

Market Cap: SEK 84.8m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

AddLife

Market Cap: SEK 22.8b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Genovis AB (publ.)

Market Cap: SEK 1.8b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Bonesupport Holding

Market Cap: SEK 17.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Egetis Therapeutics

Market Cap: SEK 1.5b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Diamyd Medical

Market Cap: SEK 1.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Biosergen

Market Cap: SEK 128.7m

A biotech company, develops antifungal products.

Swedencare

Market Cap: SEK 6.6b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Curasight

Market Cap: DKK 110.1m

A biotech company, develops treatment of cancer.

Initiator Pharma

Market Cap: SEK 226.9m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Sprint Bioscience

Market Cap: SEK 54.0m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Scandion Oncology

Market Cap: SEK 3.2m

A clinical-stage biotechnology company, develops medicines for the treatment of cancer.

AcuCort

Market Cap: SEK 167.3m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Vicore Pharma Holding

Market Cap: SEK 1.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Quia Pharma

Market Cap: SEK 7.7m

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

Annexin Pharmaceuticals

Market Cap: SEK 186.4m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Xspray Pharma

Market Cap: SEK 1.5b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Ascelia Pharma

Market Cap: SEK 489.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Xintela

Market Cap: SEK 296.3m

A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.

Hamlet BioPharma

Market Cap: SEK 653.0m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Corline Biomedical

Market Cap: SEK 241.0m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Lipigon Pharmaceuticals

Market Cap: SEK 13.5m

Develops drugs for lipid related diseases in Sweden.

Elicera Therapeutics

Market Cap: SEK 259.7m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

AcouSort

Market Cap: SEK 71.7m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Nanologica

Market Cap: SEK 103.0m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

FluoGuide

Market Cap: SEK 531.2m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Karolinska Development

Market Cap: SEK 258.5m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Attana

Market Cap: SEK 29.0m

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Orexo

Market Cap: SEK 680.4m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Abera Bioscience

Market Cap: SEK 125.9m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.